Inventor · disambiguated record
Ray J. Difalco
Also filed as: DIFALCO RAY · DIFALCO RAY J
24 granted patents·14 pending applications·64 citations·filing 2008–2020
94Inventor score
Files withSHAH MANISH S12OHEMO LIFE SCIENCES INC6CEROVENE INC4GALDERMA SA3INSPIRION DELIVERY SCIENCES LLC3
Top patents by PatentIndex Score
38 records- 0195US7955619B2Abuse resistant drugs, method of use and method of makingINSPIRION DELIVERY TECHNOLOGIES LLC·Filed 2010·Granted Jun 7, 2011·47 cites·20 claims
- 0292US8652516B1Doxycycline formulations, and methods of treating rosaceaGALDERMA SA·Filed 2013·Granted Feb 18, 2014·15 cites·29 claims
- 0378US11278500B2Abuse resistant forms of extended release hydrocodone, method of use and method of makingOHEMO LIFE SCIENCES INC·Filed 2014·Granted Mar 22, 2022·0 cites·19 claims
- 0478US11191730B2Abuse resistant forms of immediate release hydromorphone, method of use and method of makingOHEMO LIFE SCIENCES INC·Filed 2014·Granted Dec 7, 2021·0 cites·15 claims
- 0577US11291634B2Abuse resistant forms of extended release oxymorphone, method of use and method of makingOHEMO LIFE SCIENCES INC·Filed 2014·Granted Apr 5, 2022·0 cites·16 claims
- 0677US11285112B2Abuse resistant forms of immediate release oxymorphone, method of use and method of makingOHEMO LIFE SCIENCES INC·Filed 2014·Granted Mar 29, 2022·0 cites·13 claims
- 0777US10675246B2Orally administrable compositions comprising calciumCEROLIFE LLC·Filed 2014·Granted Jun 9, 2020·2 cites·11 claims
- 0872US10314788B2Pharmaceutical compositions configured to deter dosage form splittingSHAH MANISH S·Filed 2009·Granted Jun 11, 2019·0 cites·138 claims
- 0970US10736850B2Abuse resistant oral opioid formulationsSHAH MANISH S·Filed 2008·Granted Aug 11, 2020·0 cites·116 claims
- 1070US2019209480A1Pharmaceutical compositions configured to deter dosage form splittingINSPIRION DELIVERY SCIENCES LLC·Filed 2019·Application pending·0 cites
- 1169US10729657B2Abuse resistant forms of extended release morphine, method of use and method of makingINSPIRION DELIVERY TECH LLC·Filed 2014·Granted Aug 4, 2020·0 cites·23 claims
- 1268US11045422B2Abuse resistant drugs, method of use and method of makingSHAH MANISH S·Filed 2011·Granted Jun 29, 2021·0 cites·12 claims
- 1368US10702480B2Abuse resistant forms of extended release morphine, method of use and method of makingINSPIRION DELIVERY TECH LLC·Filed 2014·Granted Jul 7, 2020·0 cites·24 claims
- 1468US2015044282A1Abuse resistant forms of immediate release oxycodone, method of use and method of makingINSPIRION DELIVERY TECHNOLOGIES LLC·Filed 2014·Application pending·0 cites
- 1566US10688055B2Abuse resistant forms of extended release morphine, method of use and method of makingINSPIRION DELIVERY SCIENCES LLC·Filed 2014·Granted Jun 23, 2020·0 cites·19 claims
- 1665US10736852B2Abuse resistant oral opioid formulationsSHAH MANISH S·Filed 2012·Granted Aug 11, 2020·0 cites·95 claims
- 1765US10729656B2Abuse resistant forms of immediate release oxycodone, method of use and method of makingSHAH MANISH S·Filed 2012·Granted Aug 4, 2020·0 cites·52 claims
- 1863US10736851B2Abuse resistant forms of extended release morphine with oxycodone, method of use and method of makingSHAH MANISH S·Filed 2011·Granted Aug 11, 2020·0 cites·38 claims
- 1963US10695298B2Abuse resistant forms of extended release hydromorphone, method of use and method of makingSHAH MANISH S·Filed 2011·Granted Jun 30, 2020·0 cites·39 claims
- 2063US10688054B2Abuse resistant forms of extended release morphine, method of use and method of makingSHAH MANISH S·Filed 2011·Granted Jun 23, 2020·0 cites·54 claims
- 2163US10688053B2Abuse resistant forms of extended release hydrocodone, method of use and method of makingSHAH MANISH S·Filed 2011·Granted Jun 23, 2020·0 cites·39 claims
- 2263US10688052B2Abuse resistant forms of extended release oxymorphone, method of use and method of makingSHAH MANISH S·Filed 2011·Granted Jun 23, 2020·0 cites·50 claims
- 2363US10420726B2Abuse deterrent compositions and methods of useINSPIRION DELIVERY TECH LLC·Filed 2014·Granted Sep 24, 2019·0 cites·12 claims
- 2462US11571390B2Abuse deterrent compositions and methods of useOHEMO LIFE SCIENCES INC·Filed 2014·Granted Feb 7, 2023·0 cites·20 claims
- 2559US2014271834A1Doxycycline Formulations, and Methods of Treating RosaceaCEROVENE INC·Filed 2013·Application pending·0 cites
- 2659US2016106764A1Doxycycline Formulations, and Methods of Treating RosaceaGALDERMA SA·Filed 2015·Application pending·0 cites
- 2758US2015245998A1Doxycycline Formulations, and Methods of Treating RosaceaGALDERMA SA·Filed 2015·Application pending·0 cites
- 2858US2010291201A1Coated pharmaceutical capsule dosage formCEROVENE INC·Filed 2009·Application pending·0 cites
- 2955US11141414B2Pharmaceutical compositions comprising a pH-dependent component and pH-raising agentOHEMO LIFE SCIENCES INC·Filed 2014·Granted Oct 12, 2021·0 cites·14 claims
- 3054US2020297640A1Orally administrable compositions comprising calciumCEROLIFE LLC·Filed 2020·Application pending·0 cites
- 3153US2014275148A1Orally administrable, self-supporting dissolving film dosage formsNovus Pharma LLC·Filed 2014·Application pending·0 cites
- 3253US2012244216A1Coated pharmaceutical capsule dosage formSHAH MANISH S·Filed 2012·Application pending·0 cites
- 3352US2015104505A1Coated pharmaceutical capsule dosage formCEROVENE INC·Filed 2014·Application pending·0 cites
- 3451US2009253801A1Novel Antiarrhythmic Drug FormulationsSHAH MANISH J·Filed 2009·Application pending·0 cites
- 3551US2015005334A1Abuse deterrent compositions and methods of useINSPIRION DELIVERY TECHNOLOGIES LLC·Filed 2014·Application pending·0 cites
- 3650US10729685B2Orally administrable compositions and methods of deterring abuse by intranasal administrationINSPIRION DELIVERY SCIENCES LLC·Filed 2014·Granted Aug 4, 2020·0 cites·5 claims
- 3747US2014271845A1Coated substrate compositionsCEROVENE INC·Filed 2014·Application pending·0 cites
- 3838US2011245967A1Secure Method for Delivering Regulated Items Including Drugs to a PatientSHAH MANISH S·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ray J. Difalco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →